Partnership
2 articles

Explainers
Metsera IPO and Edison Scientific's New Partnership
Metsera's initial public offering secured approximately $275.
David Grossman·June 29, 2026

Cosmos & Space
Alnylam partners with Inceptive Nucleics for AI-driven RNAi therapeutics
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, just committed $30 million upfront and up to $2 billion to Silicon Valley biotech startup Inceptive Nucleics.
Marcus Cole·June 4, 2026